Z-1542-2018Class III
Alere iScreen Dx Urine Drug Screen Card
Ameditech, Inc. / initiated 2017-12-15 / Terminated / root cause: labeling and UDI
Ameditech Inc began a recall of Alere iScreen Dx Urine Drug Screen Card on . FDA classified it as Class III and gives the reason as "The kit box label incorrectly identifies Phencyclidine (PCP), where it should list Tricyclic Antidepressants (TCA) as one of the 10 drug analytes included in the kit box". As of , the recall status on record is Terminated, and MDM tags the root cause as labeling and UDI.
Recall record
- Recall number
- Z-1542-2018
- Classification
- Class III
- Status
- Terminated
- Initiated
- Posted
- Terminated
- Recalling firm
- Ameditech, Inc.
- Product
- Alere iScreen Dx Urine Drug Screen Card
- Product code
- LFH U.V. Spectrometry, Tricyclic Antidepressant Drugs
- Reason for recall
- The kit box label incorrectly identifies Phencyclidine (PCP), where it should list Tricyclic Antidepressants (TCA) as one of the 10 drug analytes included in the kit box.
- Root cause tag
- labeling and UDI
- FDA root cause
- Labeling Change Control
- Action
- Customers were notified on about 12/15/2017. Instructions included to become aware of the recall so as to relay the information to customers with questions.
- Quantity in commerce
- 828 kits (20,700 devices)
- Distribution
- Distributed domestically to AZ, FL, IL, ND, NV, PA, TN, TX, VA.
- Product codes and lots
- Part No. X11-IS10-Dx, Lot No. 173351, 173686, 174055, 176002.
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-1542-2018 | Class III | Terminated | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
